These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26546797)

  • 1. [Regulation (EU) No 536/2014 on Clinical Trials and Vulnerable Groups].
    Mariño Hernández EL
    Cuad Bioet; 2015; 26(88):427-30. PubMed ID: 26546797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New Royal Decree on clinical trials: main implications for emergency medicine physicians who do research].
    García Arenillas M; Haj-Ali Saflo O; Sáenz de Tejada M
    Emergencias; 2017 Jun; 29(3):194-201. PubMed ID: 28825241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
    Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the German Medicinal Product Act imposed by the EU regulation on clinical trials].
    Nickel L; Seibel Y; Frech M; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):804-811. PubMed ID: 28664271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the new EU Regulation on clinical trials adequately protect vulnerable research participants?
    Gennet É; Andorno R; Elger B
    Health Policy; 2015 Jul; 119(7):925-31. PubMed ID: 25951954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Harmonisation of regulatory requirements for clinical trials on medicinal products for human use in the Directive 2001/20/EC and complementary guidance. Implementation of the 12th Law Amending the German Drug Law].
    Geisler I; Hofmann HP; Nickel L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):141-6. PubMed ID: 15726454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research involving adults lacking capacity to consent: the impact of research regulation on 'evidence biased' medicine.
    Shepherd V
    BMC Med Ethics; 2016 Sep; 17(1):55. PubMed ID: 27609355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatology: obtaining a patient consent in clinical trials.
    Dimond B
    Br J Nurs; 2006 May 11-24; 15(9):500-1. PubMed ID: 16723924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research involving cognitively impaired adults.
    Karlawish JH
    N Engl J Med; 2003 Apr; 348(14):1389-92. PubMed ID: 12672869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Change of law concerning drug trials is needed: Sweden should allow testing in unconscious patients].
    Fagrell B; Riddez L
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3217-8. PubMed ID: 20101831
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.
    Welch MJ; Lally R; Miller JE; Pittman S; Brodsky L; Caplan AL; Uhlenbrauck G; Louzao DM; Fischer JH; Wilfond B
    Clin Trials; 2015 Oct; 12(5):503-10. PubMed ID: 26374681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research ethics and revised law regarding the Danish Central Scientific Ethical Committee].
    Kamper-Jørgensen F
    Ugeskr Laeger; 2004 Jun; 166(24):2337-40. PubMed ID: 15281571
    [No Abstract]   [Full Text] [Related]  

  • 13. Ambiguous articles in new EU Regulation may lead to exploitation of vulnerable research subjects.
    Westra AE
    J Med Ethics; 2016 Mar; 42(3):189-91. PubMed ID: 26729732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reforming the EU Clinical Trials Directive: streamlining processes or a radical "new" agenda?
    McHale JV
    Eur J Health Law; 2013 Sep; 20(4):363-81. PubMed ID: 23977734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should participation in vaccine clinical trials be mandated?
    Sheehy S; Meyer J
    Virtual Mentor; 2012 Jan; 14(1):35-8. PubMed ID: 23116915
    [No Abstract]   [Full Text] [Related]  

  • 16. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
    Welzing L; Harnischmacher U; Weyersberg A; Roth B
    Eur J Pediatr; 2007 Nov; 166(11):1169-76. PubMed ID: 17333274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.
    Med Etika Bioet; 2002; 9(1-2):12-9. PubMed ID: 16276663
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical research in children: the pros and cons of extending the legal boundaries].
    Visser HK
    Ned Tijdschr Geneeskd; 2010; 154():A2395. PubMed ID: 20858300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical research involving incapacitated adults: implications of the EU Clinical Trials Directive 2001/20/EC.
    Liddell K; Bion J; Chamberlain D; Druml C; Kompanje E; Lemaire F; Menon D; Vrhovac B; Wiedermann CJ
    Med Law Rev; 2006; 14(3):367-417. PubMed ID: 16928731
    [No Abstract]   [Full Text] [Related]  

  • 20. [Decree on the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use].
    Schwerdtfeger WK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):147-54. PubMed ID: 15726455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.